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Supplemental Experimental Method  
The analysis of air sampling media and surface wipe extracts for organophosphate flame 
retardants (OPFRs): tris(1-chloro-2-propyl) phosphate (TCPP) and tris(1,3-dichloro-2-propyl) phosphate 
(TDCPP), were completed by the ultra-performance liquid chromatography (UPLC) - atmospheric 
pressure photoionization (APPI) tandem mass spectrometry method modified from La Guardia et al. 
(2015). Briefly, media were subjected to accelerated solvent extraction (ASE 200, Dionex, Sunnyvale, 
CA, USA) with dichloromethane (DCM). Surrogate standards (6000 ng of deuterated tris (1,3-dichloro-
2-propyl) phosphate (dTDCPP); MPI for Biophysical Chemistry, Goettingen, Germany, 630 ng of 
deuterated triphenyl phosphate (d15-TPP); Sigma-Aldrich, Corp., St. Louis, MO., USA) are added to 
each sample prior to extraction. For hand wipe only: extracts are purified by size exclusion 
chromatography (SEC, Envirosep-ABC®, 350 x 21.1 mm. column; Phenomenex, Torrance, CA, USA). 
Eluent DCM, at 5 mL min.-1. For all media: each post-SEC extract is solvent exchanged to hexane, 
reduced in volume and added to the top of a solid phase 2-g silica glass extraction column (Isolute, 
International Sorbent Tech.; Hengoed Mid Glamorgan, UK). Each column is eluted with 3.5-mL hexane 
(fraction one), followed by 6.5 mL of 60:40 hexane/DCM and 8 mL DCM (fraction two) and 5 ml 50:50 
acetone/DCM (fraction three). Fraction three containing OPFRs are reduced, solvent exchanged to 
methanol and 800 ng of decachlorodiphenyl ether (DCDE) (AccuStandard, New Haven, CT., USA) is 
added as an internal standard. Analytes in the purified extract are chromatographically separated by 
UPLC (Acquity UPLC, Waters Corporation, Milford, MA., USA) operated in the gradient mode (100% 
 
 
 
methanol (A1) and 100% water (B1)), equipped with a C18 UPLC analytical column (Acquity UPLC 
BEH C18, 1.7μm, 2.1x150 mm, Waters Corp.). Analytes are ionized by APPI, the dopant (acetone) is 
introduced (150 μl min-1) by a liquid chromatography pump (LC-20AD, Shimadzu Corporation, Kyoto, 
Japan) and product ions are detected by triple quadrupole mass spectrometer (3200 QTrap, AB Sciex, 
Framingham, MA., USA) operated in the Multiple Reaction Monitoring (MRM) mode for TCPP and 
dTDCPP (quantitation ions m/z 35 ([35Cl]-), 37([37Cl]-)). 
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Table S1. TCPP and TDCPP percent by weight in bulk samplesA 
 
State 
Company 
Located 
Brand Year 
sample 
collected 
Product  Open 
or 
Closed 
Cured 
TDCPP 
% 
Cured 
TCPP   
% 
Side B   
TCPP   
% 
PA Lapolla 2017 Foam-Lok 400 
(Houston, TX) 
Open 0.0202 3.20 35.42 
PA Lapolla 2017 Foam-Lok CCRR-
1025 (Houston, TX) 
Closed 0.0124 1.24 7.85 
PA Demilec 2017 Heatlok XT 
(Arlington, TX) 
Closed B B 1.94 
RI Icynene 2015 LD-C-50™ 
(Mississauga, Ontario, 
Canada) 
Open ND 12.05 18.35 
RI Icynene 2015 MD-C-200™ 
(Mississauga, Ontario, 
Canada) 
Closed ND 3.14; 
1.95C 
6.84 
TN Bayer/CertainTeed 2015 BaySeal CCX ISO 
(Pittsburgh, PA) 
/Certaspray X (Valley 
Forge, PA) 
Open ND 13.31 20.63 
TN Bayer 2015 Bayseal OC 
(Pittsburgh, PA) 
Open ND 8.69 20.63 
TN Bayer 2015 Bayseal CCX 
(Pittsburgh, PA) 
Closed ND 2.96 3.99 
TN CertainTeed 2015 Certaspray X (Valley 
Forge, PA) 
Open 0.0961 12.67 D 
TN Unknown E 2015 Unknown Open ND 12.5 C,D  B 
KS Demilec 2015 Heatlok Soy 200 
(Arlington, TX) 
Closed ND 5.51 4.24 
KS Demilec  2015-- Sealection 500 
(Arlington, TX) 
Open ND 17.36 16.78 
NY Demilec 2017 Heatlok Highlift 
(Arlington, TX) 
Closed ND 0.99 7.06 
NY NCFI 
Polyurethane 
2017 InsulBloc R-11-017-
GL (Mount Airy, NC) 
Closed ND 0.42 2.86 
OH PSI (Preferred 
Solutions Inc) 
2015 Staycell One Step 255 
(Cleveland, OH) 
Closed ND 1.22 6.28 
A. LOD was 0.10 – 100 µg/g for TCPP and TDCPP.  
B. Sample was not collected at this site. 
C. Two samples of cured foam were taken. 
D. An error occurred within the contract lab during analysis. 
E. Workers identified the cured foam as open-cell that had been sprayed on a previous day, but we were not able to determine the 
brand and type. 
  
 
 
 
Table S2. Summary of TCPP percent by weight in bulk samplesA 
 CuredC Side B 
TypeB N Median (%) GM (GSD) (%) N Median (%) GM (GSD) (%) 
Closed 8 1.59 1.68 (2.13) 8 5.26 4.66 (1.59) 
Open 7 12.46B 9.23 (1.66) 4 19.49 17.73 (1.33) 
A. LOD was 0.10 – 100 µg/g for TCPP and TDCPP.  
B. Open vs closed: p value < 0.001 for paired t-test.  
C. Includes two cured samples where the brand was unknown 
  
 
 
 
Table S3. TCPP TWA air sampling concentrationsA using paired t-test and one-way analysis of variance (μg/m3) 
 N Median GM (GSD) 25th -  75th 
percentiles 
Range  P-value 
Overall 29 39.6 48.5 (3.63) 25.5 – 120 2.62 – 519  
Job Position      0.025D 
Sprayer 13 98.7 87.1 (3.10) 37.5 – 162 15.5 – 519  
Helper 16 30.8 30.2 (3.47) 18.8 – 79.5  2.62  - 196  
Respirators Worn During SprayingB   0.969E 
None       
Sprayer 1 37.1 C C C  
Helper 7 39.6 42.3 (4.28) 25.5 – 145 2.62 – 196  
Half-face air-
purifying 
      
Sprayer 4 135 132 (3.09) 59.6 – 354 37.5 – 519  
Helper 6 25.6 24.5 (2.60) 14.7 – 28.8 6.58 – 120  
Full-face air-
purifying 
 
      
Sprayer 2 88.8 50.2 (5.25) C 15.5 – 162  
Helper 1 39.6 C C C  
Supplied air 
 
       
Sprayer 6 108 91.6 (3.20) 41.8 – 157  16.1 – 483   
Helper 2 31.6 14.9 (7.05) 3.75 – 59.4 3.75 – 59.4  
A. All samples were above LOD. LOD for TCPP was 1, 8, or 15.6 ng/sample for OVS samples 
B. Air was sampled outside of the respirator.  
C. Not enough samples to calculate central tendencies. 
D. Paired t-test was utilized for comparisons.  
E. One-way analysis of variance (ANOVA) was utilized for comparisons for respirator (none, half-face air-purifying, 
full-face air-puifying, and supplied air).  
  
 
 
 
Table S4. TDCPP hand wipe sampling concentrationsA,B,C (ng/wipe) 
Job Position Sample 
Collection 
N Median GM 
(GSD) 
25th -  75th 
percentiles 
Range 
Sprayer Pre 9 157 112 (4.79) 62.5 – 233 <LOD – 828 
Sprayer Post 9 261 240 (2.28) 187 – 329 67.4 – 830 
Helper Pre 6 292 325 (3.10) 122 – 731 92.2 – 1840 
Helper Post 6 278 324 (2.37) 168 – 749 115 – 1,060 
Total  30 234 215 (3.29) 128 – 360 <LOD – 1,840 
GlovesD       
No  2 E E E 321 – 749 
Yes  8 177 180 (2.23) 95.8 – 266 67.4 – 830 
Intermittent  5 E E E 235 – 1,060 
Hand washingD       
Yes  8 321 267 (2.26) 168 – 585 67.4 – 749 
No  7 250 273 (2.42) 175 – 551 76.5 – 1,060 
A. TDCPP was measured at four of six companies. 
B. LOD is 5 or 10 ng/sample for dermal samples 
C. Differences were not significant between sprayer pre- and post-shift, helper pre- and post-shift, gloves or hand 
washing. 
D. Results include only post samples 
E. Not enough samples to calculate central tendencies.  
 
  
 
 
 
Table S5. Urine sampling concentrationsA using paired t-test and student’s t-test (μg/g cr) 
AnalyteB Sample 
Collection 
N No. 
<LODA
(%) 
Median GM     
(GSD) 
25th -  75th 
%tiles 
Range P-value 
BCPP         
 Pre 29 0  (0) 13.7 16.2 
(4.45) 
4.82 – 40.7 1.79 – 830  
< 
0.001E  Post  29 0  (0) 37.2 35.0 
(3.82) 
19.8 – 57.6 1.78 – 1,620 
 Total 58 0  (0) 29.9 23.8 
(4.30) 
8.99 – 52.1 1.78 – 1,620  
 
< 0.001F BCPP General 
PopulationC 
Total  924 376 
(40.7) 
0.15 0.16 
(2.71) 
0.08 – 0.28 0.01 – 27.0 
BDCPP         
 Pre 29 0  (0) 2.59 2.60 
(2.33) 
1.84 – 3.81 0.23 – 25.7  
0.491E 
 Post 29 0  (0) 2.42 2.79 
(2.26) 
1.79 – 4.92 0.32 – 16.8  
 Total 58 0  (0) 2.53 2.69 
(2.28) 
1.79 – 4.36 0.23 – 25.7  
 
< 0.001F BDCPP General 
PopulationC 
Total 911 69     
(7.6) 
0.65 0.66 
(2.77) 
0.32 – 1.30 0.05 – 67.9 
BCEtP         
 Pre 29 3   (10) 0.36 0.44  
(2.77) 
0.26 – 0.98 0.04 – 2.17 
0.435E  Post 29 2    (6.9) 0.43 0.46  
(3.14) 
0.26 – 1.01 0.03 – 21.2 
 Total 58 5    (8.6) 0.41 0.45 
(2.93) 
0.26 – 1.01 0.03 – 21.2  
 
0.711F BCEtP General 
PopulationC 
Total 920 105  
(11.4) 
0.32 0.38  
(3.23) 
0.17 – 0.73 0.02 – 147 
DBuP         
 Pre 29 4    (14) 0.11 0.14 
(4.28) 
0.04 – 0.19 0.04 – 0.42 
0.131E  Post 29 4     (14)  0.14 0.24 
(6.16) 
0.08 – 0.51 0.01 – 22.0 
 Total 58 9     (14) 0.13 0.18 
(5.15) 
0.04 – 0.08 0.01 – 22.0  
 
0.059F DBUP General 
PopulationC 
 922 184     
(20) 
0.18 0.16 
(2.38) 
0.10 – 0.27 0.01 – 9.00 
DPhP         
 Pre 29 1    (3.4) 0.68 0.74 
(2.66) 
0.40 – 1.04 0.17 – 19.9 
0.  500E  Post 29 1    (3.4) 0.86 0.94 
(1.88) 
0.69 – 1.31 0.245 – 4.66 
 Total 58 2   (3.4) 0.76 0.83 
(2.28) 
0.55 – 1.16 0.169 – 19.9  
 
0.166F 
 
 
 
 
Table S5. Urine sampling concentrationsA using paired t-test and student’s t-test (μg/g cr), continued 
AnalyteB Sample 
Collection 
N No. 
<LODA(
%) 
Median GM     
(GSD) 
25th -  75th 
%tiles 
Range P-value 
DPhP General 
PopulationC 
Total 921 85    
(9.2) 
0.55 0.58 
(2.25) 
0.34 – 0.94 0.04 – 29.6  
DpCP         
 Pre 29 20     
(69) 
D D D 0.01 – 0.18  
D 
 Post 29 23  (79) D D D 0.01 – 0.19 
 Total 58 43   (74) D D D 0.01 – 0.19  
 
D 
DpCP General 
PopulationC 
Total 924 815    
(88) 
D D 0.02 – 0.06 0.01 – 5.14 
TBBA         
 Pre 29 22    
(76) 
D D D 0.01 – 0.97 
D 
 Post 29 18   (62) D D D 0.01 – 0.69 
 Total 58 40   (69) D D D 0.01 – 0.97  
 
D 
TBBA General 
PopulationB 
 924 882   
(95) 
D D 0.02 – 0.05 0.01 – 5.14 
A. Limit of detection (LOD) for each analyte in μg/L: BCPP =0.10, BDCPP =0.11, BCEtP=0.08, DBuP =0.05, DPHP =0.16, DpCP 
=0.05, TBBA=0.05. 
B. Not listed in table due to all samples being below LOD: DBzB=0.05, DoCP=0.05 μg/L. 
C. Ospina, M; Jayatilaka, N; Wong, L; Restrepo, P., Calafat AM.  Exposure to organophosphate flame retardant chemicals in the U.S. 
general population: Data from the 2013–2014 National Health and Nutrition Examination Survey.  Environ. Int., 2018, 110,32-41 
Includes male aged 18 +.  
D. Not enough samples above LOD to calculate central tendencies. 
E. Paired t-test was utilized for pre/post comparisons. 
F. Student’s t-test was utilized for SPF workers to the general population (male aged 18+). 
  
 
 
 
Table S6. Urine sampling concentrations adjusted for specific gravityA using paired t-test (μg/L) 
AnalyteB Sample 
Collection 
N No. 
<LODA 
(%) 
Median GM  
(GSD) 
25th - 75th 
Percentiles 
Range  P-value 
BCPP         
 Pre 29 0 (0) 24.0 28.9 
(4.49) 
10.1 – 81.5 2.31 – 1,740 
< 0.001  Post 29 0 (0) 70.5 76.4 
(4.05) 
43.0 – 122 3.71 – 5,240 
 Total 58 0 (0) 52.9 47.0 
(4.57) 
13.4 – 104 2.31 – 5,240  
BDCPP         
 Pre 29 0 (0) 4.43 4.63 
(2.55) 
2.63 – 7.25 0.34 – 53.8 
0.043  Post 29 0 (0) 5.67 6.08 
(2.52) 
3.32 – 13.0 0.87 – 54.4 
 Total 58 0 (0) 4.74 5.30     
(2.54) 
3. 05 – 8.78 0.34 – 54.4  
BCEtP         
 Pre 29 3 (10) 0.75 0.79 
(3.01) 
0.38 – 2.10 0.04 – 5.03 
0.361  Post 29 2 (6.9) 1.07 1.00 
(3.19) 
0.69 – 1.72 0.07 – 68.6 
 Total 58 5 (8.6) 1.03 0.89 
(3.16) 
0.41 – 1.81 0.04 – 68.6  
DBuP         
 Pre 29 4 (14) 0.169 0.24 
(4.49) 
0.10 – 0.32 0.04 – 10.3 
0.126  Post 29 4 (14)  0.313 0.52 
(6.25) 
0.16 – 1.40 0.03 – 48.6 
 Total 58 8 (14) 0.243 0.36 
(5.50) 
0.12 – 0.85 0.03 – 48.6  
DPhP          
 Pre 29 1 (3.4) 1.43 1.32 
(2.37) 
0.68 – 1.92 0.45 – 27.0 
0.818  Post 29 1 (3.4) 1.82 2.04 
(2.07) 
1.44 – 3.31 0.27 – 7.97 
 Total 58 2 (3.4) 1.62 1.65 
(2.28) 
0.95 – 2.65 0.27 – 27.0  
DpCP         
 Pre 29 20 (69) C C C 0.03 – 0.29  C  Post 29 23 (79) C C C 0.03 – 0.32 
 Total 58 43 (74) C C C 0.03 – 0.32  
TBBA         
 Pre 29 22 (72) C C C 0.03 – 2.02 C  Post 29 18 (60) C C C 0.03 – 2.24 
 Total 58 40 (69) C C C 0.03 – 2.24  
A. Limit of detection (LOD) for each analyte in μg/L: BCPP =0.10, BDCPP =0.11, BCEtP=0.08; DBuP =0.05;  
DPHP =0.16;  DpCP =0.05, TBBA=0.05 
B. Not listed in table due to all concentrations being below LOD: DBzB=0.05, DoCP=0.05 μg/L. 
C. Not enough samples above LOD to calculate central tendencies.  
 
 
 
Table S7. Urine sampling concentrationsA adjusted for specific gravity using paired t-test (μg/L) 
 
Analyte Sample 
Collection 
Job 
Position 
N Median GM (GSD)  25th -  75th 
%tiles 
Range  P-value 
BCPPA         
 Pre Sprayer 13 81.5 66.5 (4.37) 21.5 – 114 8.42 – 1,740 0.007  Post Sprayer 13 93.4 156 (3.94) 58.3 – 233 43.0 – 5,240 
 Pre Helper 16 12.3 14.7 (3.24) 5.71 – 43.6 2.31 – 118 0.003  Post Helper 16 50.8 42.7 (3.19) 21.4 – 97.9 3.71 – 257 
BDCPPA         
 Pre Sprayer 13 4.50 4.71 (3.23) 3.05 – 7.25 0.34 – 53.8 0.085  Post Sprayer 13 5.67 6.55 (3.21) 2.94 – 17.6 0.87 – 54.4 
 Pre Helper 16 4.10 4.56 (2.09) 2.59 – 7.41 1.27 – 18.0 0.247  Post Helper 16 6.05 5.73 (2.02) 3.53 – 9.21 1.74 – 15.5 
A. Limit of detection (LOD) for each analyte in μg/L: BDCPP =0.11, BCPP =0.10. All samples were above the LOD 
 
